中国医药导报
中国医药期刊欢迎您 今天是   2025年1月5日星期天
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床医学-肿瘤 本期目录 | 过刊浏览 | 高级检索 |
乳腺癌组织中NM23及上皮钙黏素的表达与新辅助化疗效果的关系
杨磊1      杨宏伟1      陈茂山1      牟德武1      程晓明2
1.四川省遂宁市中心医院乳腺甲状腺外科,四川遂宁   629000;
2.遵义医科大学附属医院甲状腺乳腺外科,贵州遵义   563000
Relationship between the expression of NM23 and E-cadherin and the efficacy of neoadjuvant chemotherapy in breast cancer#br#
YANG Lei1   YANG Hongwei1   CHEN Maoshan1   MU Dewu1   CHENG Xiaoming2
1.Department of Breast and Thyroid Surgery, Suining Central Hospital, Sichuan Province, Suining   629000, China; 
2.Department of Thyroid and Breast Surgery, Affiliated Hospital of Zunyi Medical University, Guizhou Province, Zunyi   563000, China
全文: PDF (500 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨乳腺癌组织中NM23和上皮钙黏素的表达与新辅助化疗(NCT)效果的关系。 方法 收集遵义医科大学附属医院甲状腺乳腺外科2014年10月至2017年10月收治的浸润性乳腺癌并接受NCT患者87例的临床资料。根据NCT效果将其分为有效组(63例)和无效组(24例)。采用免疫组化方法检测87例浸润性乳腺癌患者NCT前癌组织中NM23和上皮钙黏素的表达,分析NM23和上皮钙黏素的表达与NCT效果的关系。 结果 无效组的NM23阳性、TNM分期为Ⅲ期、人表皮生长因子受体-2阳性占比均低于有效组,上皮钙黏素阳性占比高于有效组,差异有统计学意义(P < 0.05)。多因素分析结果显示,上皮钙黏素表达阳性是乳腺癌NCT无效的独立危险因素(OR > 1,P < 0.05),NM23表达阳性及TNM分期为Ⅲ期是其保护因素(OR < 1,P < 0.05)。 结论 乳腺癌组织的NM23和上皮钙黏素表达均与乳腺癌NCT效果存在显著相关性,对评估乳腺癌患者NCT后的效果有一定的参考价值。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
杨磊1 杨宏伟1 陈茂山1 牟德武1 程晓明2
关键词 乳腺癌NM23上皮钙黏素新辅助化疗相关性    
Abstract:Objective To investigate the relationship between the expression of NM23 and E-cadherin and the efficacy of neoadjuvant chemotherapy (NCT) in breast cancer. Methods The clinical data of 87 patients with invasive breast cancer who received NCT were collected from Department of Thyroid and Breast Surgery, Affiliated Hospital of Zunyi Medical University from October 2014 to October 2017. According to the effect of NCT, they were divided into effective group (63 cases) and ineffective group (24 cases). The expression of NM23 and E-cadherin in NCT precancerous tissues of 87 patients with invasive breast cancer was detected by immunohistochemical method, and the relationship between the expression of NM23 and E-cadherin and the effect of NCT was analyzed. Results The proportion of NM23 positive, TNM stage Ⅲ, and human epidermal growth factor receptor-2 positive in ineffective group were lower than those in effective group, and the proportion of E-cadherin positive was higher than that in effective group, the differences were statistically significant (P < 0.05). Multivariate analysis showed that positive E-cadherin expression was an independent risk factor for NCT inefficacy in breast cancer (OR > 1, P < 0.05), while positive NM23 expression and TNM stage Ⅲ were protective factors (OR < 1, P < 0.05). Conclusion The expression levels of NM23 and E-cadherin in breast cancer tissues are significantly correlated with the effect of NCT in breast cancer, which has certain reference value for evaluating the effect of breast cancer patients after NCT.
Key wordsBreast cancer    NM23    E-cadherin    Neoadjuvant chemotherapy    Correlation
    
基金资助:重庆市科学技术局超声医学工程国家重点实验室面上项目(2020KFKT011)。
通讯作者: 程晓明(1965.7-),女,硕士,硕士生导师;研究方向:甲状腺乳腺疾病诊疗及其进展。   
作者简介: 杨磊(1986.10-),男,硕士;研究方向:乳腺癌及甲状腺常见疾病诊疗及大数据分析。
引用本文:   
杨磊1 杨宏伟1 陈茂山1 牟德武1 程晓明2. 乳腺癌组织中NM23及上皮钙黏素的表达与新辅助化疗效果的关系[J]. 中国医药导报, 2022, 19(8): 93-96.
YANG Lei1 YANG Hongwei1 CHEN Maoshan1 MU Dewu1 CHENG Xiaoming2. Relationship between the expression of NM23 and E-cadherin and the efficacy of neoadjuvant chemotherapy in breast cancer#br#. 中国医药导报, 2022, 19(8): 93-96.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2022/V19/I8/93

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司